Venrock Adviser, LLC Diversified Active

Location: New York, NY

CIK: 0001615982 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: May 15, 2023

Total Value: $594M (100.0% shares, 0.0% debt)

Holdings (28)

VRDN VIRIDIAN THERAPEUTICS INC 13.3%
Value $78.86M Shares 2,699,865 Est. Cost $19.47 Unrealized +18.4%
ACRS ACLARIS THERAPEUTICS INC 12.1%
Value $71.88M Shares 4,563,962 Est. Cost $13.57 Unrealized +18.5%
AXSM AXSOME THERAPEUTICS INC 8.7%
Value $51.73M Shares 670,718 Est. Cost $59.77 Unrealized 0.0%
COGT COGENT BIOSCIENCES INC 7.9%
Value $46.68M Shares 4,038,117 Est. Cost $7.95 Unrealized +55.9%
TERN TERNS PHARMACEUTICALS INC 6.4%
Value $37.75M Shares 3,707,891 Est. Cost $3.72 Unrealized +79.1%
GHRS GH RESEARCH PLC 5.8%
Value $34.19M Shares 3,517,125 Est. Cost $17.34 Unrealized -37.6%
CELC CELCUITY INC 5.0%
Value $29.5M Shares 2,105,386 Est. Cost $10.24 Unrealized 0.0%
DICE THERAPEUTICS INC 4.3%
Value $25.55M Shares 819,000 Est. Cost $21.00 Unrealized
AEROVATE THERAPEUTICS INC 3.7%
Value $21.91M Shares 747,869 Est. Cost $16.40 Unrealized
PLRX PLIANT THERAPEUTICS INC 3.5%
Value $20.88M Shares 1,080,000 Est. Cost $19.13 Unrealized +9.3%
KALV KALVISTA PHARMACEUTICALS INC 3.3%
Value $19.72M Shares 2,916,667 Est. Cost $5.36 Unrealized 0.0%
NVAX NOVAVAX INC 3.3%
Value $19.33M Shares 1,879,894 Est. Cost $17.65 Unrealized 0.0%
MERUS N V 3.2%
Value $18.97M Shares 1,226,214 Est. Cost $15.47 Unrealized
CABA CABALETTA BIO INC 3.0%
Value $17.53M Shares 1,895,285 Est. Cost $3.64 Unrealized 0.0%
ANNX ANNEXON INC 2.8%
Value $16.65M Shares 3,220,050 Est. Cost $4.00 Unrealized +37.4%
VECTIVBIO HLDG AG 2.7%
Value $16.17M Shares 1,866,000 Est. Cost $8.66 Unrealized
PROVENTION BIO INC 2.0%
Value $11.82M Shares 1,118,653 Est. Cost $7.32 Unrealized
SVRA SAVARA INC 1.7%
Value $9.845M Shares 6,351,531 Est. Cost $1.32 Unrealized +4.1%
MIST MILESTONE PHARMACEUTICALS IN 1.5%
Value $8.747M Shares 2,208,812 Est. Cost $7.58 Unrealized -30.6%
LIANY LIANBIO 1.3%
Value $7.861M Shares 4,793,047 Est. Cost $6.16 Unrealized
MARINUS PHARMACEUTICALS INC 1.2%
Value $7.047M Shares 1,770,705 Est. Cost $11.98 Unrealized
TRVI TREVI THERAPEUTICS INC 1.0%
Value $5.887M Shares 3,050,022 Est. Cost $2.46 Unrealized -19.8%
FULC FULCRUM THERAPEUTICS INC 0.5%
Value $3.257M Shares 447,326 Est. Cost $7.16 Unrealized -8.9%
LYRA THERAPEUTICS INC 0.5%
Value $2.902M Shares 924,170 Est. Cost $5.65 Unrealized
INOZYME PHARMA INC 0.5%
Value $2.845M Shares 2,709,987 Est. Cost $4.77 Unrealized
ATYR ATYR PHARMA INC 0.4%
Value $2.565M Shares 1,171,436 Est. Cost $5.98 Unrealized -60.6%
AFFIMED N V 0.3%
Value $1.771M Shares 1,428,571 Est. Cost $5.52 Unrealized
RALLYBIO CORP 0.3%
Value $1.764M Shares 268,532 Est. Cost $7.55 Unrealized